Johnson & Johnson (JNJ) Stock Analysis

Johnson & Johnson (JNJ) is a publicly traded company in the HEALTHCARE sector. It trades at $222.96, carries a market capitalization of $538.04B, a price-to-earnings ratio of 25.90, a dividend yield of 0.02%. This page summarizes the public market data, fundamentals, and frequently asked questions for JNJ, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

Market Sentiment

Johnson & Johnson currently has a Bullish sentiment score of 0.20.

About Johnson & Johnson

Johnson & Johnson (JNJ) is a premier American multinational corporation, founded in 1886, that operates across three main segments: medical devices, pharmaceuticals, and consumer health products. Renowned for its commitment to innovation and quality, J&J plays a pivotal role in the global healthcare landscape and is consistently recognized as one of the world's most valuable enterprises. As a prominent member of the Dow Jones Industrial Average with a coveted AAA credit rating, the company ex...

GNG Research Analysis

GNG Research scores Johnson & Johnson (JNJ) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for JNJ.

Frequently Asked Questions

What is JNJ's current dividend yield?

Johnson & Johnson (JNJ) has a current dividend yield of 0.02%.

Does JNJ pay dividends?

Yes, Johnson & Johnson pays dividends with a current yield of 0.02%.

What is JNJ's P/E ratio?

Johnson & Johnson has a price-to-earnings (P/E) ratio of 25.90.

What is JNJ's market cap?

Johnson & Johnson (JNJ) has a market capitalization of $538.04B with a current stock price of $222.96.